Andrew B. Gerry - Concepedia

Concepedia

Author

Andrew B. Gerry

Adaptimmune (United Kingdom)

Also Known As

A B Gerry, A. Gerry, A.B. Gerry, Andrew B Gerry, Andrew B. Gerry, Andrew Gerry

52

Publications

3.6K

Citations

18

H-Index

36

Concepts

All Affiliations

Adaptimmune (United Kingdom)University of Reading University of Maryland, Baltimore Washington University in St. Louis University of Pennsylvania

AB

About

Andrew B. Gerry is an author at Adaptimmune (United Kingdom) specializing in medicine, oxidative stress, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.2K
2	Biochemistry	3	3	111
3	Engineering	1	1	35
4	Public Health	1	1	164
5	Allergy	1	1	20

Andrew B. Gerry

×

23

Publications

3.6K

Citations

18

H-Index

	Year	Citations
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma Gerald P. Linette, Edward A. Stadtmauer, Marcela V. Maus, Blood	2013	1.1K
NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl, Nature Medicine Cancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint InhibitorAntigen-specific Antitumor Effects	2015	832
Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells Brian Cameron, Andrew B. Gerry, Joseph Dukes, Science Translational Medicine	2013	660
Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men Sabine Tricon, Graham C. Burdge, E. Linn Jones, American Journal of Clinical Nutrition Lipid AnalysisNutritionLipid NutritionMedicineDairy Products	2006	164
T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells Maw Pin Tan, Andrew B. Gerry, Jared Brewer, Clinical & Experimental Immunology	2014	134
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy Joseph P. Sanderson, Darragh Crowley, Guy E. Wiedermann, OncoImmunology Cell TherapyT-regulatory CellImmunologyAntigen ProcessingImmune Cell Therapy	2019	91
Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate E.C. Border, Joseph P. Sanderson, Thomas Weissensteiner, OncoImmunology	2018	63
Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells Giovanna Bossi, Andrew B. Gerry, Samantha Paston, OncoImmunology	2013	56
Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation Wai-man R. Wong, Andrew B. Gerry, W. Putt, Atherosclerosis Apolipoprotein A-iv DifferOxysterolBiochemistryGeneticsGenetic Epidemiology	2006	56
Tuning T‐Cell Receptor Affinity to Optimize Clinical Risk‐Benefit When Targeting Alpha‐Fetoprotein–Positive Liver Cancer Roslin Y. Docta, Tiago Ferronha, Joseph P. Sanderson, Hepatology	2018	51

Page 1